Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib

Overview of attention for article published in Clinical Cancer Research, November 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 3 news outlets
twitter: 19 X users

patent: 12 patents
f1000: 1 research highlight platform

Readers on

mendeley: 172 Mendeley

So far, Altmetric has seen 19 X posts from 19 X users, with an upper bound of 111,134 followers.

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib http://t.co/IqDYuTSKTG

http://t.co/F2HXeIYBai Trop forts, ces Bostonais. La résistance au ceretinib demasquée.

Two Novel #ALK Mutations Mediate Acquired #Resistance to the Next-Generation ALK Inhibitor #Alectinib. http://t.co/EekLxmpQku

Two Novel ALK Mutations Mediate Acquired Resistance to the Next-Generation ALK Inhibitor Alectinib http://t.co/YMQTXxyCcq #lcsm

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 15 additional X posts.